Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001785530-20-000001
Filing Date
2020-08-13
Accepted
2020-08-13 14:25:44
Documents
1
Effectiveness Date
2020-08-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9848
  Complete submission text file 0001785530-20-000001.txt   10933
Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-346661 | Film No.: 201098743